Compared to single biomarkers, the combination biomarker plasma NFL/Aβ1–42 demonstrated higher performance accuracy, highlighting its utility as a candidate biomarker for the early diagnosis of AD. The gene discussed is NEFL; the disease is Alzheimer disease.